{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:26:35Z","timestamp":1785929195577,"version":"3.56.0"},"reference-count":40,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T00:00:00Z","timestamp":1381449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Applied Toxicology"],"published-print":{"date-parts":[[2014,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>A simple, fast and sensitive method for the determination of quetiapine in human blood has been developed and validated. The method involved a basic liquid\u2013liquid extraction procedure and subsequent analysis by gas chromatography\u2013mass spectrometry, previous derivatization with <jats:italic>bis<\/jats:italic>(trimethylsilyl)\u2010trifluoro\u2010acetamide and chorotrimethylsilane (99 : 1). The methods of validation included linearity with a correlation coefficient\u2009&gt;\u20090.99 over the range 0.02\u20131\u2009\u00b5g\u2009ml<jats:sup>\u20131<\/jats:sup>, intra\u2010 and interday precision (always\u2009&lt;\u200912%) and accuracy (mean relative error always\u2009&lt;\u200912%) to meet the bioanalytical acceptance criteria. The limit of detection was 0.005\u2009\u00b5g\u2009ml<jats:sup>\u20131<\/jats:sup>. The procedure was further applied to post mortems from the Institute of Legal Medicine, University of Santiago de Compostela. Copyright \u00a9 2013 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/jat.2944","type":"journal-article","created":{"date-parts":[[2013,10,14]],"date-time":"2013-10-14T07:37:12Z","timestamp":1381736232000},"page":"1104-1108","source":"Crossref","is-referenced-by-count":17,"title":["Rapid determination of quetiapine in blood by gas chromatography\u2013mass spectrometry. Application to post\u2010mortem cases"],"prefix":"10.1002","volume":"34","author":[{"given":"Olga","family":"L\u00f3pez\u2010Guarnido","sequence":"first","affiliation":[{"name":"Department of Legal Medicine and Toxicology University of Granada School of Medicine  Avda. Madrid, 11 18071 Granada Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Tabernero","sequence":"additional","affiliation":[{"name":"Institute of Legal Medicine, Forensic Toxicology Service, Faculty of Medicine San Francisco  s\/n 15782 Santiago de Compostela Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio F.","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Department of Legal Medicine and Toxicology University of Granada School of Medicine  Avda. Madrid, 11 18071 Granada Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Rodrigo","sequence":"additional","affiliation":[{"name":"Department of Legal Medicine and Toxicology University of Granada School of Medicine  Avda. Madrid, 11 18071 Granada Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Bermejo","sequence":"additional","affiliation":[{"name":"Institute of Legal Medicine, Forensic Toxicology Service, Faculty of Medicine San Francisco  s\/n 15782 Santiago de Compostela Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,10,11]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2082"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2012.12.039"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/24.4.300"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp090477"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jen.2007.09.002"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G107"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2011.05.015"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2009.11.018"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200023040-00003"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mop.0000151714.87702.a9"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2011.05.002"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.12.2114"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.2672"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/30.4.287"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2010.11.024"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ftd.0000185770.44502.51"},{"key":"e_1_2_6_18_1","unstructured":"International Conference on Harmonization (ICH).1996.Guidance for Industry Q2B Validation of Analytical Procedures: Methodology.http:\/\/www.fda.gov\/downloads\/RegulatoryInformation\/Guidances\/UCM128049.pdf[accessed June 6 2013]."},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e32832bb078"},{"key":"e_1_2_6_20_1","unstructured":"JibsonMD.2012.Second\u2010generation antipsychotic medications: Pharmacology administration and comparative side effects. This topic last updated: September 7 2012 . Up To Date.http:\/\/www.uptodate.com\/contents\/second\u2010generation\u2010antipsychotic\u2010medications\u2010pharmacology\u2010administration\u2010and\u2010comparative\u2010side\u2010effects[March 2 2013]."},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.12.276"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/28.6.520"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2012.665456"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1360"},{"key":"e_1_2_6_25_1","volume-title":"Clarke's Analysis of Drugs and Poisons","author":"Moffat AC","year":"2004"},{"key":"e_1_2_6_26_1","volume-title":"Handbook of Forensic Toxicology for Medical Examiners","author":"Molina DK","year":"2010"},{"key":"e_1_2_6_27_1","doi-asserted-by":"crossref","unstructured":"M\u00fcllerC ReuterH DohmenC.2009.Intoxication after extreme oral overdose of quetiapine to attempt suicide: pharmacological concerns of side effects.Case Rep. Med. 371698.","DOI":"10.1155\/2009\/371698"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2008.03.016"},{"issue":"121","key":"e_1_2_6_29_1","first-page":"257","article-title":"Quetiapine. A me\u2010too neuroleptic; no panacea","volume":"20","author":"No Authors Listed","year":"2011","journal-title":"Prescrire Int."},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/bms001"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.2012.02385.x"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12024-012-9404-4"},{"issue":"6","key":"e_1_2_6_33_1","first-page":"52","article-title":"Development and validation of Quetiapinefumarate in pure and pharmaceutical formulation by UV\u2010spectrophotometric method","volume":"2","author":"Prasanth VG","year":"2011","journal-title":"Pharm. Sin."},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2012.10.038"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(92)80473-4"},{"key":"e_1_2_6_36_1","unstructured":"RepettoMR RepettoM.2007.Tabla de concentraciones de xenobi\u00f3ticos en fluidos biol\u00f3gicos humanos como referencia para el diagn\u00f3stico toxicol\u00f3gico. In M Repetto M (ed). Ampliaci\u00f3n de Toxicolog\u00eda de Postgrado. \u00c1rea de Toxicolog\u00eda Universidad de Sevilla: Seville; 51\u201351.http:\/\/busca-tox.com\/13conc\/Tabla%20de%20Concentraciones%20de%20Xenobioticos%20en%20fluidos%20biologicos%20como%20referencia%20para%20el%20diagnostico%20toxicologico%20Repetto.pdf"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2005.11.032"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/jat.1613"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200317050-00002"},{"key":"e_1_2_6_40_1","unstructured":"US Department of Heath and Human Services Food and Drug Administration.2001.Guidance for Industry Bioanalysis Method Validation.http:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/ucm070107.pdf[June 6 2013]."},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1520\/JFS2004068"}],"container-title":["Journal of Applied Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjat.2944","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jat.2944","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T19:47:42Z","timestamp":1760557662000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/jat.2944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,11]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["10.1002\/jat.2944"],"URL":"https:\/\/doi.org\/10.1002\/jat.2944","archive":["Portico"],"relation":{},"ISSN":["0260-437X","1099-1263"],"issn-type":[{"value":"0260-437X","type":"print"},{"value":"1099-1263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,11]]}}}